98558B309143EC3D8725869400737D4B Hearing Summary

Representative Rich, bill co-sponsor, introduced HB 21-1012. Current law requires the Prescription Drug Monitoring Program to track all controlled substances prescribed in Colorado.  Beginning February 1, 2023, the bill expands the program to track all prescription drugs prescribed in the state.  The bill extends the repeal of the program until September 1, 2028, following a sunset review.

Current law authorizes the Department of Regulatory Agencies (DORA) to collect a fee from licensees who may prescribe controlled substances.  The bill authorizes DORA to collect a fee from any licensed practitioner.

Representative Mullica, bill co-sponsor, continued introducing HB21-1012.

Lisa Raville, Harm Reduction Action Center, spoke in opposition to the bill. The witness responded to questions from the committee.

Ms. Raville continued to respond to questions from the committee.

Mr. Morgan Honea, representing the Colorado Regional Health Information Organization (CORHIO), testified in support of the bill. The witness responded to questions from the committee.

Mr. Rick Curtsinger, representing Quality Health Network, testified in support of the bill.

Dr. Kevin Borcher, representing CyncHealth, testified in support of the bill. The witness responded to questions from the committee.

Dr. Patrick Guffey, representing CORHIO, testified in support of the bill.

Tim Finnegan, representing Colorado Pharmacists Society, testified in support of the bill.

Ms. Fofi Mendez, representing RxPlus Pharmacies, testified in support of the bill. Ms. Mendez responded to questions from the committee.

Ms. Jeanette Hensley, representing Colorado Senior Lobby, testified in support of the bill.

Dr. Sami Diab, representing himself, testified in support of the bill. The witness responded to questions from the committee.

Representative Mullica provided final comments on the bill. He requested the Chair lay the bill over for action only.

Representative Rich provided final comments on the bill.

The bill sponsors responded to questions from the committee.

The Chair laid the bill over for action only.